Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics.
暂无分享,去创建一个
R. Schiffelers | G. Storm | I. Bakker-Woudenberg | S. Snijders | R M Schiffelers | G Storm | I A Bakker-Woudenberg | S V Snijders
[1] K. Edwards,et al. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. , 1998, Chemistry and physics of lipids.
[2] V. Awasthi,et al. Imaging experimental osteomyelitis using radiolabeled liposomes. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] W. Oyen,et al. Scintigraphic evaluation of experimental colitis in rabbits. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] W. Oyen,et al. Technetium-99m labelled liposomes to image experimental arthritis , 1997, Annals of the rheumatic diseases.
[5] M. Venditti,et al. The importance of in-vitro susceptibility testing in the management of compromised hosts. , 1997, Journal of chemotherapy.
[6] J. Lagacé,et al. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. , 1997, Journal of microencapsulation.
[7] W. Oyen,et al. Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] S. Hirota,et al. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. , 1996, Biochimica et biophysica acta.
[9] W. Oyen,et al. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] J. Lagacé,et al. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection , 1996, Antimicrobial agents and chemotherapy.
[11] A. Gabizon,et al. Liposome circulation time and tumor targeting: implications for cancer chemotherapy , 1995 .
[12] H. Kiwada,et al. Effect of vesicle size on in vivo release of daunorubicin from hydrogenated egg phosphatidylcholine-based liposomes into blood circulation. , 1995, Biological & pharmaceutical bulletin.
[13] M. T. ten Kate,et al. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue. , 1995, The Journal of infectious diseases.
[14] J. Butts. Intracellular Concentrations of Antibacterial Agents and Related Clinical Implications , 1994, Clinical pharmacokinetics.
[15] N. Van Rooijen,et al. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.
[16] G. Storm,et al. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. , 1993, The Journal of infectious diseases.
[17] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[18] G. Storm,et al. Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. , 1992, Biochimica et biophysica acta.
[19] K. Matthay,et al. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[20] F. Martin,et al. Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. , 1992, Biophysical journal.
[21] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[23] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[24] I. Bakker-Woudenberg,et al. Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition. , 1989, The Journal of pharmacology and experimental therapeutics.
[25] R. Nayar,et al. Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. , 1986, Chemistry and physics of lipids.
[26] I. Bakker-Woudenberg,et al. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats , 1982, Antimicrobial Agents and Chemotherapy.
[27] B. de Kruyff,et al. The function of sterols in membranes. , 1976, Biochimica et biophysica acta.
[28] G. R. Bartlett. Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.
[29] M. Woodle,et al. Long Circulating Liposomes: Old Drugs, New Therapeutics , 1998, Biotechnology Intelligence Unit.
[30] M. Woodle,et al. Long Circulating Liposome Therapeutics: From Concept to Clinical Reality , 1998 .
[31] T. Allen,et al. Liposomes , 2012, Drugs.
[32] G. Lopez-Berestein,et al. The past, present, and future uses of liposomes in treating infectious diseases. , 1995, Immunopharmacology and immunotoxicology.
[33] H. Jacobs,et al. Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the label. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[34] A. Gabizon,et al. An Improved Method for in Vivo Tracing and Imaging of Liposomes Using a Gallium 67-Deferoxamine Complex , 1988 .